SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001047469-15-009376
Filing Date
2015-12-22
Accepted
2015-12-22 16:55:42
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 a2226939zs-3.htm S-3 304475
2 EX-4.1 a2226939zex-4_1.htm EX-4.1 723936
3 EX-4.2 a2226939zex-4_2.htm EX-4.2 780421
4 EX-5.1 a2226939zex-5_1.htm EX-5.1 17890
5 EX-12.1 a2226939zex-12_1.htm EX-12.1 33844
6 EX-23.1 a2226939zex-23_1.htm EX-23.1 3969
7 G295586.JPG g295586.jpg GRAPHIC 20545
  Complete submission text file 0001047469-15-009376.txt   1894022
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-208701 | Film No.: 151302719
SIC: 2834 Pharmaceutical Preparations